CA Patent

CA3216303A1 — Capsule for specific drug delivery and preparation method therefor

Assigned to Jiangsu Hengrui Pharmaceutical Co Ltd · Expires 2022-10-27 · 4y expired

What this patent protects

A capsule for specific drug delivery and a preparation method therefor, relating to a capsule containing a non-liquid filler and a modified release coating. The modified release coating covers a capsule shell, an isolating layer is provided between the capsule shell and the modif…

USPTO Abstract

A capsule for specific drug delivery and a preparation method therefor, relating to a capsule containing a non-liquid filler and a modified release coating. The modified release coating covers a capsule shell, an isolating layer is provided between the capsule shell and the modified release coating, and no sealing film is provided between the body and cap of the capsule. The capsule can be used for delivering a drug to an intestinal track, and exhibits excellent characteristics in mass production of capsules and drug release.

Drugs covered by this patent

Patent Metadata

Patent number
CA3216303A1
Jurisdiction
CA
Classification
—
Expires
2022-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.